LYEL smart money
Lyell Immunopharma, INC. (LYEL): 4 insider buys, 2 top funds holding it in the public filings.
Insider buys, 12 months$75.0M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-11-05 | Arch Venture Partners Ix, LLC | 10% owner | $25.0M | $10.77 |
| 2026-11-05 | Arch Venture Fund Xiii, L.P. | 10% owner | $25.0M | $10.77 |
| 2026-03-09 | Arch Venture Partners Ix Overage, L.P. | TenPercentOwner | $12.5M | $25.61 |
| 2026-03-09 | Berns Paul L | TenPercentOwner | $12.5M | $25.61 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 39 | Decheng Capital LLC | 0.99% | $7M | |
| 41 | Alphabet INC. | 0.00% | $3M |